Clostridium difficile-associated colitis. Part 2: Therapy and prevention

被引:0
|
作者
Markus, P. M. [1 ]
机构
[1] Elisabeth Krankenhaus Essen Contilia GmbH, Akad Lehrkrankenhaus, Klin Allgemein Viszeral & Unfallchirurg, Klara Kopp Weg 1, D-45138 Essen, Germany
关键词
Pseudomembranous colitis; Clostridium difficile toxin A; Clostridium difficile toxin B Metronidazole; Vancomycin;
D O I
10.1007/s00053-012-0316-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Clostridium difficile is an anaerobic, Gram positive, spore-forming and toxin-producing bacillus. Colonization of the intestinal tract is facilitated by the administration of various antibiotics, in particular clindamycin, broad spectrum penicillins, fluorochinlones and cephalosporins. The clinical manifestations of C. difficile infections range from an asymptomatic carrier to fulminant disease with toxic megacolon. The cardinal clinical symptom is watery diarrhea accompanied by a pronounced leucocytosis. The most important initial step in the treatment of C. difficile - associated colitis is cessation of the responsible antibiotic. Treatment of non-severe C. difficile infection consists of oral metronidazole and patients with severe C. difficile - associated colitis are treated with oral vancomycin. The recurrence rate is high and a distinction must be made between a true reinfection with a different strain and a relapse of persistent diarrhea.
引用
收藏
页码:447 / 453
页数:7
相关论文
共 50 条
  • [21] CLOSTRIDIUM DIFFICILE-ASSOCIATED COLITIS AFTER NEOMYCIN TREATED WITH METRONIDAZOLE
    BOLTON, RP
    BRITISH MEDICAL JOURNAL, 1979, 2 (6203): : 1479 - 1480
  • [22] Fecal transplantation therapy for Clostridium difficile-associated pouchitis
    Lisa N. Patel
    Jason Schairer
    Bo Shen
    International Journal of Colorectal Disease, 2014, 29 : 263 - 264
  • [23] Vancomycin therapy for severe Clostridium difficile-associated diarrhea
    Huggan, Paul J.
    Murdoch, David R.
    CLINICAL INFECTIOUS DISEASES, 2007, 45 (12) : 1647 - 1648
  • [24] Fidaxomicin: New therapy for Clostridium difficile-associated diarrhea
    Grant, Edward M.
    FORMULARY, 2011, 46 (08) : 297 - +
  • [25] Review:: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis:: The emergence of a more virulent era
    Hookman, Perry
    Barkin, Jamie S.
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (04) : 1071 - 1075
  • [26] Clostridium difficile-associated diarrhea
    Gorbach, SL
    Bartlett, JG
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (02) : 84 - 84
  • [27] Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
    Goldenberg, Joshua Z.
    Ma, Stephanie S. Y.
    Saxton, Jane D.
    Martzen, Mark R.
    Vandvik, Per O.
    Thorlund, Kristian
    Guyatt, Gordon H.
    Johnston, Bradley C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [28] Fecal transplantation therapy for Clostridium difficile-associated pouchitis
    Patel, Lisa N.
    Schairer, Jason
    Shen, Bo
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (02) : 263 - 264
  • [29] Clostridium difficile-associated diarrhoea
    Elliott, B.
    Chang, B. J.
    Golledge, C. L.
    Riley, T. V.
    INTERNAL MEDICINE JOURNAL, 2007, 37 (08) : 561 - 568
  • [30] Review: Clostridium difficile-Associated Disorders/Diarrhea and Clostridium difficile Colitis: The Emergence of a More Virulent Era
    Perry Hookman
    Jamie S. Barkin
    Digestive Diseases and Sciences, 2007, 52 : 1071 - 1075